BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15216477)

  • 1. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
    Walling DM; Etienne W; Ray AJ; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):387-95. PubMed ID: 15216477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
    Walling DM; Flaitz CM; Nichols CM; Hudnall SD; Adler-Storthz K
    J Infect Dis; 2001 Dec; 184(12):1499-507. PubMed ID: 11740724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
    Walling DM; Flaitz CM; Nichols CM
    J Infect Dis; 2003 Sep; 188(6):883-90. PubMed ID: 12964120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
    Walling DM; Flaitz CM; Hosein FG; Montes-Walters M; Nichols CM
    J Infect Dis; 2004 May; 189(9):1656-63. PubMed ID: 15116302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.
    Walling DM; Ling PD; Gordadze AV; Montes-Walters M; Flaitz CM; Nichols CM
    J Infect Dis; 2004 Jul; 190(2):396-9. PubMed ID: 15216478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus reactivation in hairy leukoplakia.
    Brandwein M; Nuovo G; Ramer M; Orlowski W; Miller L
    Mod Pathol; 1996 Mar; 9(3):298-303. PubMed ID: 8685231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hairy leukoplakia: an Epstein-Barr virus-associated disease of patients with HIV.
    Walling DM
    Res Initiat Treat Action; 2000 Dec; 6(4):10-5. PubMed ID: 11708168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.
    Webster-Cyriaque J; Raab-Traub N
    Virology; 1998 Aug; 248(1):53-65. PubMed ID: 9705255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [EBV replication and therapy of oral hairy leukoplakia using acyclovir].
    Näher H; Helfrich S; Hartmann M; Freese UK
    Hautarzt; 1990 Dec; 41(12):680-2. PubMed ID: 1965185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein-Barr virus detection in oral hairy leukoplakia in AIDS patients, in leukoplakias and on normal tongue epithelia in HIV-1-negative patients].
    Gross G; Wiegand H; Zentgraf H
    Z Hautkr; 1988 Jan; 63(1):44-8. PubMed ID: 2833041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands.
    Frangou P; Buettner M; Niedobitek G
    J Infect Dis; 2005 Jan; 191(2):238-42. PubMed ID: 15609234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas.
    Murray PG; Niedobitek G; Kremmer E; Grässer F; Reynolds GM; Cruchley A; Williams DM; Müller-Lantzsch N; Young LS
    J Pathol; 1996 Jan; 178(1):44-7. PubMed ID: 8778314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infection fighters. High-dose Valtrex for oral hairy leukoplakia.
    TreatmentUpdate; 2003; 15(7):6-7. PubMed ID: 17216869
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity.
    Höllsberg P; Kusk M; Bech E; Hansen HJ; Jakobsen J; Haahr S
    Acta Neurol Scand; 2005 Dec; 112(6):395-402. PubMed ID: 16281923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy.
    Sunde PT; Olsen I; Enersen M; Grinde B
    J Clin Virol; 2008 Jun; 42(2):176-8. PubMed ID: 18304869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus in oral diseases.
    Slots J; Saygun I; Sabeti M; Kubar A
    J Periodontal Res; 2006 Aug; 41(4):235-44. PubMed ID: 16827715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase.
    Niedobitek G; Young LS; Lau R; Brooks L; Greenspan D; Greenspan JS; Rickinson AB
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3035-46. PubMed ID: 1662695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
    Webster-Cyriaque J; Middeldorp J; Raab-Traub N
    J Virol; 2000 Aug; 74(16):7610-8. PubMed ID: 10906215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus and Epstein Barr virus in oral hairy leukoplakia among HIV positive Venezuelan patients.
    Correnti M; González X; Avila M; Perrone M; Rivera H
    Acta Odontol Latinoam; 2010; 23(2):117-23. PubMed ID: 21053684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.